(Q52033873)

20 April 2018

title

Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice. (English)

1 reference

20 April 2018

0 references

Victoria Mendizábal

1

1 reference

20 April 2018

Andreas Zimmer

series ordinal

2

1 reference

20 April 2018

Rafael Maldonado

series ordinal

3

1 reference

20 April 2018

language of work or name

English

0 references

publication date

16 November 2005

1 reference

20 April 2018

published in

Neuropsychopharmacology

1 reference

20 April 2018

volume

31

1 reference

20 April 2018

page(s)

1957-1966

1 reference

20 April 2018

issue

9

1 reference

20 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300957

exact match

0 references

cites work

Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Cannabinoid receptors and reward in the rat: a conditioned place preference study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Distribution of dynorphin and enkephalin peptides in the rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Kappa opioid inhibition of morphine and cocaine self-administration in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Genetic differences in intravenous cocaine self-administration between C57BL/6J and DBA/2J mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Possible pharmacotherapy of the opioid kappa receptor agonist for drug dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Reinforcing and neurochemical effects of cocaine: differences among C57, DBA, and 129 mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Cannabinoid transmission and pain perception

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Blockade of the morphine-induced increase in turnover of dopamine on the mesolimbic dopaminergic system by kappa-opioid receptor activation in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Endogenous cannabinoids as an aversive or counter-rewarding system in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Drug use and drinking among students in 36 countries.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Lack of CB1 cannabinoid receptor impairs cocaine self-administration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Involvement of mesolimbic kappa-opioid systems in the discriminative stimulus effects of morphine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Psychiatric symptoms in cannabis users

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Drug seeking becomes compulsive after prolonged cocaine self-administration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Synergistic interactions of endogenous opioids and cannabinoid systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Cannabinoids in clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Differences in spatial learning comparing transgenic p75 knockout, New Zealand Black, C57BL/6, and Swiss Webster mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300957

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300957

1 reference

20 April 2018

PubMed ID

16292318

1 reference

20 April 2018